Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ Tyrosinase Recombinant Rabbit Monoclonal Antibody (6B2)

Rabbit Recombinant Monoclonal Antibody

Supplier:  Invitrogen™ MA549843

Catalog No. FEMA549843


Only null left
Add to Cart

Description

Description

Tyrosinase Recombinant Monoclonal Antibody for ICC/IF, ELISA

The enzyme encoded by this gene catalyzes the first 2 steps, and at least 1 subsequent step, in the conversion of tyrosine to melanin. The enzyme has both tyrosine hydroxylase and dopa oxidase catalytic activities, and requires copper for function. Mutations in this gene result in oculocutaneous albinism, and nonpathologic polymorphisms result in skin pigmentation variation. The human genome contains a pseudogene similar to the 3' half of this gene.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Tyrosinase
Recombinant Monoclonal
1 mg/mL
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
P14679
TYR
A synthesized peptide derived from human Tyrosinase.
100 μL
Primary
Human
Antibody
IgG
ELISA, Immunocytochemistry
6B2
Unconjugated
TYR
albino; albino locus protein; ATN; C; CMM8; LB24-AB; monophenol monooxygenase; Oca1; OCA1A; OCAIA; oculocutaneous albinism IA; SHEP3; SK29-AB; skc35; Tumor rejection antigen AB; TYR; Tyrosinase; tyrosinase (oculocutaneous albinism IA); tyrosinase precursor
Rabbit
Affinity chromatography
RUO
7299
-20°C or -80°C if preferred
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.